Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited was incorporated in 1996 and brings 3 decades of experience to its industry. Corporate Identification Number is L24232GJ1996PLC029894 and its registration number is 29894. It belongs to the classification of company limited by shares as per MCA records. Authorized capital of the company is recorded at ₹40.00 crore. The paid-up share capital amounts to ₹23.39 crore.
It deals mainly in manufacture of chemicals and chemical products processes. The company’s registration location is Ahmedabad. The company is incorporated with the address Plot No 502/17 Gidc Estate Ankleshwar Gidc, Bharuch, Ankleshwar, Gujarat, India, 393002. Its current corporate status is active. Tatva Chintan Pharma Chem Limited holds PAN AABCT0623N. The company’s Legal Entity Identifier (LEI) code is 335800I28VDPT9WEFU68. Tatva Chintan Pharma Chem Limited can be contacted at chintan@tatvachintan.com. Senior management roles are held by Ajesh Kumar Pillai (CFO) and Ajesh Kumar Pillai (CFO).
Company Overview
- CIN
- Date of Incorporation
- 11/06/1996
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 31/03/2025
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹40,00,00,000.00
- Paid up Capital
- ₹23,39,20,550.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- chintan@tatvachintan.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Gujarat | 24AABCT0623N3ZE | Active |
| 24AABCT0623N1ZG | Active | |
| 24AABCT0623N2ZF | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE0GK401011 | TATVA CHINTAN PHARMA CHEM LIMITED EQ | - | 12/10/2026 | TATVA CHINTAN/SH VTG | ESVUFN |
| IN80GK401012 | TATVA CHINTAN PHARMA CHEM LIMITED EQ LISTING/ TRADING APPROVAL AWAITED | - | 12/10/2026 | TATVA CHINTAN/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹62,749.50L | ₹54,708.70L | ₹49,946.20L | ₹42,651.50L | ₹0.00L |
| Net Debt | ₹11,460.90L | ₹2,501.40L | ₹0.00L | ₹14,289.20L | ₹5,692.10L |
| Gross PPE | ₹74,792.90L | ₹63,403.00L | ₹55,990.50L | ₹46,156.70L | ₹0.00L |
| Inventory | ₹19,607.40L | ₹13,395.40L | ₹15,276.60L | ₹16,249.80L | ₹0.00L |
| Total Debt | ₹12,037.30L | ₹3,638.80L | ₹1,427.10L | ₹17,025.70L | ₹0.00L |
| Common Stock | ₹2,339.20L | ₹2,339.20L | ₹2,339.20L | ₹2,216.50L | ₹0.00L |
| Current Debt | ₹11,536.30L | ₹3,638.80L | ₹1,363.20L | ₹16,602.70L | ₹0.00L |
| Share Issued | ₹233.92L | ₹233.92L | ₹233.92L | ₹221.65L | ₹0.00L |
| Total Assets | ₹1,00,369.40L | ₹83,624.90L | ₹81,871.80L | ₹75,885.70L | ₹0.00L |
| Capital Stock | ₹2,339.20L | ₹2,339.20L | ₹2,339.20L | ₹2,216.50L | ₹0.00L |
| Long Term Debt | ₹501.00L | ₹0.00L | ₹63.90L | ₹423.00L | ₹0.00L |
| Current Assets | ₹34,951.20L | ₹26,524.50L | ₹29,790.60L | ₹31,225.00L | ₹0.00L |
| Prepaid Assets | ₹2,307.60L | ₹2,590.90L | ₹2,331.60L | ₹1,589.30L | ₹0.00L |
| Working Capital | ₹13,637.70L | ₹16,921.80L | ₹21,824.30L | ₹7,355.90L | ₹0.00L |
| Financial Assets | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Invested Capital | ₹90,213.20L | ₹77,521.20L | ₹75,135.30L | ₹68,504.80L | ₹0.00L |
| Other Properties | ₹5,407.00L | ₹5,515.40L | ₹4,620.80L | ₹1,690.10L | ₹0.00L |
| Retained Earnings | ₹34,841.90L | ₹30,853.00L | ₹30,771.20L | ₹28,220.40L | ₹0.00L |
| Common Stock Equity | ₹78,175.90L | ₹73,882.40L | ₹73,708.20L | ₹51,479.10L | ₹0.00L |
| Net Tangible Assets | ₹77,493.30L | ₹73,292.50L | ₹73,312.10L | ₹51,431.50L | ₹0.00L |
| Tangible Book Value | ₹77,493.30L | ₹73,292.50L | ₹73,312.10L | ₹51,431.50L | ₹0.00L |
| Current Liabilities | ₹21,313.50L | ₹9,602.70L | ₹7,966.30L | ₹23,869.10L | ₹0.00L |
| Long Term Provisions | ₹258.90L | ₹139.80L | ₹133.40L | ₹114.50L | ₹0.00L |
| Stockholders Equity | ₹78,175.90L | ₹73,882.40L | ₹73,708.20L | ₹51,479.10L | ₹0.00L |
| Other Equity Interest | ₹75,836.70L | ₹71,543.20L | ₹71,369.00L | ₹49,262.60L | ₹0.00L |
| Total Capitalization | ₹78,676.90L | ₹73,882.40L | ₹73,772.10L | ₹51,902.10L | ₹0.00L |
| Hedging Assets Current | ₹0.00L | ₹27.20L | ₹0.00L | ₹51.60L | ₹0.00L |
| Ordinary Shares Number | ₹233.92L | ₹233.92L | ₹233.92L | ₹221.65L | ₹0.00L |
| Other Intangible Assets | ₹682.60L | ₹589.90L | ₹396.10L | ₹47.60L | ₹0.00L |
| Other Non Current Assets | ₹134.20L | ₹111.20L | ₹83.20L | ₹55.10L | ₹0.00L |
| Total Non Current Assets | ₹65,418.20L | ₹57,100.40L | ₹52,081.20L | ₹44,660.70L | ₹0.00L |
| Cash And Cash Equivalents | ₹576.40L | ₹1,137.40L | ₹3,530.40L | ₹2,736.50L | ₹0.00L |
| Construction In Progress | ₹2,334.80L | ₹2,153.50L | ₹7,292.70L | ₹23,074.40L | ₹0.00L |
| Accumulated Depreciation | -₹12,043.40L | -₹8,694.30L | -₹6,044.30L | -₹3,505.20L | ₹0.00L |
| Additional Paid In Capital | ₹40,439.40L | ₹40,439.40L | ₹40,439.40L | ₹20,902.60L | ₹0.00L |
| Other Short Term Investments | ₹34.00L | ₹32.70L | ₹1,036.40L | ₹1,385.00L | ₹0.00L |
| Other Non Current Liabilities | ₹120.10L | ₹0.00L | ₹0.00L | ₹0.00L | ₹1.70L |
| Machinery Furniture Equipment | ₹43,669.90L | ₹35,551.70L | ₹25,431.80L | ₹13,088.80L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹682.60L | ₹589.90L | ₹396.10L | ₹47.60L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹78,175.90L | ₹73,882.40L | ₹73,708.20L | ₹51,479.10L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹22,193.50L | ₹9,742.50L | ₹8,163.60L | ₹24,406.60L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹11,536.30L | ₹3,638.80L | ₹1,363.20L | ₹16,602.70L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹501.00L | ₹0.00L | ₹63.90L | ₹423.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹610.40L | ₹1,170.10L | ₹4,566.80L | ₹4,121.50L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹880.00L | ₹139.80L | ₹197.30L | ₹537.50L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net Income | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L | ₹0.00L |
| Free Cash Flow | -₹8,228.50L | -₹5,149.80L | -₹3,047.10L | -₹17,532.70L | ₹0.00L |
| Changes In Cash | -₹542.10L | -₹2,401.70L | ₹802.30L | -₹3,556.60L | ₹0.00L |
| End Cash Position | ₹576.40L | ₹1,137.40L | ₹3,530.40L | ₹2,736.50L | ₹0.00L |
| Financing Cash Flow | ₹7,893.20L | ₹1,659.30L | ₹3,051.90L | ₹3,779.50L | ₹0.00L |
| Investing Cash Flow | -₹11,584.20L | -₹6,538.40L | -₹12,054.00L | -₹10,114.40L | ₹0.00L |
| Operating Cash Flow | ₹3,148.90L | ₹2,477.40L | ₹9,804.40L | ₹2,778.30L | ₹0.00L |
| Capital Expenditure | -₹11,377.40L | -₹7,627.20L | -₹12,851.50L | -₹20,311.00L | ₹0.00L |
| Beginning Cash Position | ₹1,137.40L | ₹3,530.40L | ₹2,736.50L | ₹6,301.70L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| EBIT | ₹5,962.70L | ₹847.50L | ₹4,971.90L | ₹5,277.60L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹9,647.40L | ₹3,613.40L | ₹7,532.40L | ₹6,233.10L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹26,344.10L | ₹17,195.80L | ₹20,770.20L | ₹18,630.00L |
| Pretax Income | ₹5,700.90L | ₹757.90L | ₹4,356.80L | ₹4,477.90L |
| Tax Provision | ₹1,495.50L | ₹186.60L | ₹1,321.40L | -₹70.80L |
| Total Revenue | ₹50,062.00L | ₹37,990.10L | ₹39,049.50L | ₹42,089.10L |
| Cost Of Revenue | ₹23,717.90L | ₹20,794.30L | ₹18,279.30L | ₹23,459.10L |
| Total Expenses | ₹44,121.70L | ₹37,299.20L | ₹34,637.30L | ₹36,215.60L |
| Interest Income | ₹71.30L | ₹48.70L | ₹328.40L | ₹533.40L |
| Interest Expense | ₹261.80L | ₹89.60L | ₹615.10L | ₹799.70L |
| Operating Income | ₹5,940.30L | ₹690.90L | ₹4,412.20L | ₹5,873.50L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹9,653.40L | ₹3,618.20L | ₹7,542.30L | ₹6,609.90L |
| Normalized Income | ₹4,209.83L | ₹574.92L | ₹3,042.30L | ₹4,812.46L |
| Operating Expense | ₹20,403.80L | ₹16,504.90L | ₹16,358.00L | ₹12,756.50L |
| Operating Revenue | ₹50,062.00L | ₹37,990.10L | ₹39,049.50L | ₹42,089.10L |
| Net Interest Income | -₹242.60L | -₹102.50L | -₹344.60L | -₹326.60L |
| Total Unusual Items | -₹6.00L | -₹4.80L | -₹9.90L | -₹376.80L |
| Basic Average Shares | ₹233.92L | ₹233.92L | ₹228.89L | ₹221.65L |
| Diluted Average Shares | ₹233.92L | ₹233.92L | ₹228.89L | ₹221.65L |
| Total Other Finance Cost | ₹52.10L | ₹61.60L | ₹57.90L | ₹60.30L |
| Other Operating Expenses | ₹7,076.20L | ₹5,401.70L | ₹5,632.20L | ₹4,213.30L |
| Reconciled Depreciation | ₹3,684.70L | ₹2,765.90L | ₹2,560.50L | ₹955.50L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹23,717.90L | ₹20,794.30L | ₹18,279.30L | ₹23,459.10L |
| Rent Expense Supplemental | ₹171.20L | ₹161.10L | ₹154.40L | ₹187.80L |
| Tax Effect Of Unusual Items | -₹1.57L | -₹1.18L | -₹3.00L | -₹113.04L |
| Interest Income Non Operating | ₹71.30L | ₹48.70L | ₹328.40L | ₹533.40L |
| Selling And Marketing Expense | ₹3,085.10L | ₹2,609.90L | ₹2,235.80L | ₹2,876.60L |
| Interest Expense Non Operating | ₹261.80L | ₹89.60L | ₹615.10L | ₹799.70L |
| Net Income Common Stockholders | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L |
| Net Income Continuous Operations | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L |
| Diluted NIAvailto Com Stockholders | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L |
| General And Administrative Expense | ₹611.60L | ₹550.70L | ₹589.00L | ₹506.70L |
| Selling General And Administration | ₹3,696.70L | ₹3,160.60L | ₹2,824.80L | ₹3,383.30L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹6.00L | -₹4.80L | -₹9.90L | -₹376.80L |
| Net Non Operating Interest Income Expense | -₹242.60L | -₹102.50L | -₹344.60L | -₹326.60L |
| Net Income Including Noncontrolling Interests | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L |
| Net Income From Continuing And Discontinued Operation | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L |
| Net Income From Continuing Operation Net Minority Interest | ₹4,205.40L | ₹571.30L | ₹3,035.40L | ₹4,548.70L |
Company Performance (FY23–FY26)
₹500.6 Cr₹375.5 Cr₹250.3 Cr₹125.2 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 12/06/1996 | Chintan Nitinkumar Shah | 00183618 | Managing Director | View other directorships |
| 12/06/1996 | Shekhar Rasiklal Somani | 00183665 | Whole-time director | View other directorships |
| 12/06/1996 | Ajaykumar Mansukhlal Patel | 00183745 | Whole-time director | View other directorships |
| 27/02/2021 | Avani Rajesh Umatt | 09046170 | Director | View other directorships |
| 27/02/2021 | Manher Chimanlal Desai | 09042598 | Director | View other directorships |
| 27/02/2021 | Subhash Ambubhai Patel | 00535221 | Director | View other directorships |
| 17/01/2022 | Ishwar Ramanbhai Nayi | *****4130H | Company Secretary | |
| 31/10/2025 | Ajesh Kumar Pillai | *****3444L | CFO |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 8
- Chintan Nitinkumar ShahManaging Director
- Ajaykumar Mansukhlal PatelWhole-time director
- Shekhar Rasiklal SomaniWhole-time director
- Avani Rajesh UmattDirector
- Manher Chimanlal DesaiDirector
- Subhash Ambubhai PatelDirector
- Ajesh Kumar PillaiCFO
- Ishwar Ramanbhai NayiCompany Secretary
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 19/11/2024 | Form MGT-7-19112024_signed | - |
| 10/11/2024 | Form Addendum to AOC-4 CSR-09112024 | - |
| 14/10/2024 | Form AOC-4(XBRL)-14102024 | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AA1976669 | 24/08/2022 | ₹45,00,00,000.00 | State Bank Of India |
| AA2021592 | 14/06/2022 | ₹35,00,00,000.00 | Dbs Bank India Limited |
| AC1254107 | 01/01/2021 | ₹1,10,00,000.00 | Axis Bank Limited |
| AC1266777 | 31/12/2020 | ₹1,10,00,000.00 | Axis Bank Limited |
| AC1255177 | 31/12/2020 | ₹1,10,00,000.00 | Axis Bank Limited |
| AB4447609 | 21/11/2019 | ₹10,00,00,000.00 | Citi Bank N.a. |
| T69065464 | 29/12/2017 | ₹26,50,00,000.00 | Citi Bank N.a. |
| AA6589552 | 17/01/2017 | ₹85,00,00,000.00 | Citi Bank N.a. |
| AA6035450 | 20/11/2015 | ₹65,50,00,000.00 | Icici Bank Limited |
| T32911166 | 04/11/2015 | ₹58,25,00,000.00 | Icici Bank Limited |
| R50096957 | 11/07/2015 | ₹67,57,000.00 | Icici Bank Limited |
| R50092790 | 03/07/2015 | ₹67,57,000.00 | Icici Bank Limited |
| R50098730 | 03/07/2015 | ₹67,57,000.00 | Icici Bank Limited |
| AA6249458 | 14/10/2014 | ₹65,50,00,000.00 | Icici Bank Limited |
| C61112678 | 12/04/2012 | ₹2,00,00,000.00 | Bank Of Baroda |
| C61112504 | 03/10/2006 | ₹13,60,000.00 | Bank Of Baroda |
| C56071418 | 27/05/2005 | ₹24,82,00,000.00 | Bank Of Baroda |
| C56072598 | 28/04/2005 | ₹24,82,00,000.00 | Bank Of Baroda |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Plot No 502/17 Gidc Estate Ankleshwar Gidc, Bharuch, Ankleshwar, Gujarat, India, 393002
Frequently Asked Questions
What is the incorporation date of Tatva Chintan Pharma Chem Limited?
The incorporation date of Tatva Chintan Pharma Chem Limited is 11/06/1996.
What is the authorized share capital and paid-up capital of Tatva Chintan Pharma Chem Limited?
The authorized share capital of Tatva Chintan Pharma Chem Limited is ₹40,00,00,000.00. The paid-up capital is ₹23,39,20,550.00.
Who are the current board members & directors of Tatva Chintan Pharma Chem Limited?
The current board member of Tatva Chintan Pharma Chem Limited are:
- Chintan Nitinkumar Shah
- Shekhar Rasiklal Somani
- Ajaykumar Mansukhlal Patel
- Avani Rajesh Umatt
- Manher Chimanlal Desai
- Subhash Ambubhai Patel
- Ishwar Ramanbhai Nayi
- Ajesh Kumar Pillai
What is the registered address of Tatva Chintan Pharma Chem Limited?
The registered address of Tatva Chintan Pharma Chem Limited is Plot No 502/17 Gidc Estate Ankleshwar Gidc, Bharuch, Ankleshwar, Gujarat, India, 393002.
What is the Corporate Identification Number of Tatva Chintan Pharma Chem Limited?
The Corporate Identification Number of Tatva Chintan Pharma Chem Limited is L24232GJ1996PLC029894.